Type of surgery | Reintervention (%/year) | Thrombo-embolic event (%/year) | Endocarditis (%/year) | Composite valve-related event (%/year) | |
Groenink10 1999 | TRR | 0.6 (−0.2 to 1.5) | NR | NR | –† |
Gott11 1999 | TRR | 0.2 (0.1 to 0.4) | 0.7 (0.4 to 0.9) | 0.6 (0.4 to 0.8) | 1.5 (1.1 to 1.8) |
Alexiou12 2001 | TRR | 0.2 (−0.2 to 0.6) | 1.0 (0.1 to 1.9) | 0.2 (−0.2 to 0.6) | 1.3 (0.3 to 2.3) |
de Oliveira13 2003 | TRR | 1.9 (0.2 to 3.5) | 0.7 (−0.3 to 1.8) | 1.1 (−0.1 to 2.4) | 3.6 (1.4 to 5.9) |
Karck14 2004 | TRR | 0.9 (0.2 to 1.6) | 0.8 (0.1 to 1.4) | 0.3 (−0.1 to 0.7) | 1.8 (0.8 to 2.9) |
Zehr15 2005 | TRR | 0.4 (−0.2 to 0.6) | 1.1 (0.1 to 2.0) | 0.2 (−0.2 to 0.6) | 0.2 (−0.2 to 0.6) |
Patel16 2008 | TRR | 0.2 (−0.2 to 0.6) | 0.9 (0.1 to 1.8) | 0.1 (−0.2 to 0.4) | 1.1 (0.2 to 2.0) |
Birks17 1999 | VSRR | 2.6 (1.1 to 4.1) | 0.2 (−0.2 to 0.7) | 0.2 (−0.2 to 0.7) | 2.9 (1.3 to 4.5) |
Gott11 1999 | VSRR | 0.3 (−0.3 to 0.9) | 0.3 (0.3 to 0.9) | 0.1 (−0.3 to 0.6) | 0.6 (−0.2 to 1.4) |
Kallenbach18 2007 | VSRR | 2.6 (0.7 to 4.6) | 0.4 (−0.4 to 1.1) | 0.2 (0.3 to 0.7) | 3.0 (0.9 to 5.1) |
Settepani19 2007 | VSRR | 5.4 (−0.7 to 11.6) | 0.9 (−1.6 to 3.4) | 1.8 (−1.7 to 5.4) | 7.2 (0.1 to 14.3) |
Patel16 2008 | VSRR | 2.4 (0.3 to 4.5) | 0.5 (−0.5 to 1.4) | 0.2 (−0.4 to 0.9) | 2.9 (0.6 to 5.1) |
David20 2009 | VSRR | 0.4 (−0.1 to 0.9) | 0.4 (−0.1 to 0.9) | 0.1 (−0.1 to 0.4) | 0.9 (0.2 to 1.6) |
Overall TRR | 0.3 (0.1 to 0.5) | 0.7 (0.5 to 0.9) | 0.3 (0.2 to 05) | 1.3 (0.6 to 2.0) | |
Overall VSRR | 1.3 (0.3 to 2.2) | 0.3 (0.1 to 0.6) | 0.2 (−0.0 to 0.3) | 1.9 (0.8 to 2.9) | |
Heterogeneity test | TRR | χ2 7.8 (p=NS) | χ2 1.4 (p=NS) | χ2 10.1 (p=NS) | χ2 30.0 (p<0.001) |
I2=24% | I2=0% | I2=50% | I2=83% | ||
VSRR | χ2 17.6 (p=0.004) | χ2 0.6 (p=NS) | χ2 1.02 (p=NS) | χ2 14.7 (p=0.01) | |
I2=71% | I2=0% | I2=0% | I2=66% | ||
Total Between | χ2 4.8 (p=0.02) | χ2 5.6 (p=0.01) | χ2 1.9 (p=NS) | χ2 0.6 (p=NS) |